Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases
Clinical trial NCT00060138 · COMPLETED
Trial details
- NCT number
- NCT00060138
- Sponsor
- Chugai Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2004-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.